Generic Name and Formulations:
Miconazole 50mg; buccal tablet.
Midatech Pharma US Inc.
Indications for ORAVIG:
Local treatment of oropharyngeal candidiasis.
Do not crush, chew, or swallow. Alternate application site. Apply to upper gum region, hold in place for 30 seconds to ensure adhesion. ≥16yrs: 50mg once daily in the AM for 14 consecutive days.
<16yrs: not recommended.
Allergy to milk protein concentrate.
History of hypersensitivity to azoles; monitor and discontinue if allergic reactions develop. Hepatic Impairment. Pregnancy (Cat.C). Nursing mothers.
May potentiate anticoagulant effects with warfarin (monitor PT, INR, evidence of bleeding). Caution with drugs metabolized by CYP2C9 and CYP3A4 (eg, oral hypoglycemics, phenytoin, ergot alkaloids).
Diarrhea, headache, nausea, dysgeusia, upper abdominal pain, vomiting, possible allergic reactions.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Ketamine Infusions Reduce Suicidal Ideation in Depression: Characterizing Different Responses
- Text Message Reminders Improve Medication Adherence in Bipolar I Disorder
- Improving Medication Adherence in ADHD Lowers Risk for Oppositional Defiant Disorder, Conduct Disorder in Adulthood
- High Suicidality Among Children With ADHD Mediated by Family Functioning, Psychiatry Comorbidities
- Pilot Study Investigates Lithium vs Quetiapine for Bipolar Spectrum Disorder
- How Personalized Hospital Ratings May Drive Patient-Specific Care in the Digital Age